Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic appearance of primary appendiceal lymphoma.
Furuse M, Aoyagi K, Esaki M, Shigemura T, Nakamura S, Hizawa K, Kozuki T, Yao T, Kimura Y, Fujishima M. Furuse M, et al. Among authors: kozuki t. Gastrointest Endosc. 1998 Jul;48(1):86-7. doi: 10.1016/s0016-5107(98)70139-7. Gastrointest Endosc. 1998. PMID: 9684675 No abstract available.
Depressed type early cancer in ulcerative colitis.
Okada N, Matsumoto T, Jo Y, Kozuki T, Hizawa K, Mibu R, Yao T, Fujishima M. Okada N, et al. Among authors: kozuki t. Gastrointest Endosc. 2000 Dec;52(6):754. doi: 10.1067/mge.2000.110740. Gastrointest Endosc. 2000. PMID: 11115911 No abstract available.
Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study.
Horinouchi H, Murakami H, Harada H, Sobue T, Kato T, Atagi S, Kozuki T, Tokito T, Oizumi S, Seike M, Ohashi K, Mio T, Sone T, Iwao C, Iwane T, Koto R, Tsuboi M. Horinouchi H, et al. Among authors: kozuki t. Lung Cancer. 2024 Nov 14;199:108027. doi: 10.1016/j.lungcan.2024.108027. Online ahead of print. Lung Cancer. 2024. PMID: 39708388 Free article.
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.
Umemura S, Udagawa H, Ikeda T, Murakami H, Daga H, Toyozawa R, Kozuki T, Sakakibara-Konishi J, Ohe Y, Morise M, Kato T, Shingyoji M, Hara S, Furuya N, Teranishi S, Takata S, Miyamoto S, Nakachi I, Wakabayashi M, Nomura S, Sato A, Ishii G, Tsuchihara K, Sugiyama E, Kirita K, Sakai T, Shibata Y, Izumi H, Nosaki K, Zenke Y, Matsumoto S, Yoh K, Niho S, Goto K. Umemura S, et al. Among authors: kozuki t. J Thorac Oncol. 2024 Oct 10:S1556-0864(24)02378-5. doi: 10.1016/j.jtho.2024.10.004. Online ahead of print. J Thorac Oncol. 2024. PMID: 39395663
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.
Morgensztern D, Ready N, Johnson ML, Dowlati A, Choudhury N, Carbone DP, Schaefer E, Arnold SM, Puri S, Piotrowska Z, Hegde A, Chiang AC, Iams W, Tolcher A, Nosaki K, Kozuki T, Li T, Santana-Davila R, Akamatsu H, Murakami H, Yokouchi H, Wang S, Zha J, Li R, Robinson RR, Hingorani P, Jeng EE, Furqan M. Morgensztern D, et al. Among authors: kozuki t. Clin Cancer Res. 2024 Nov 15;30(22):5042-5052. doi: 10.1158/1078-0432.CCR-24-1547. Clin Cancer Res. 2024. PMID: 39287821 Free PMC article. Clinical Trial.
Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue.
Doi H, Ohmura K, Hashimoto M, Ueno K, Takase Y, Inaba R, Kozuki T, Iwasaki T, Taniguchi M, Tabuchi Y, Shirakashi M, Onizawa H, Tsuji H, Onishi A, Watanabe R, Kitagori K, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Yamamoto W, Itaya T, Uozumi R, Tanaka M, Morinobu A. Doi H, et al. Among authors: kozuki t. Lupus. 2024 Oct;33(12):1336-1344. doi: 10.1177/09612033241281909. Epub 2024 Sep 14. Lupus. 2024. PMID: 39276161
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.
Ahn MJ, Tanaka K, Paz-Ares L, Cornelissen R, Girard N, Pons-Tostivint E, Vicente Baz D, Sugawara S, Cobo M, Pérol M, Mascaux C, Poddubskaya E, Kitazono S, Hayashi H, Hong MH, Felip E, Hall R, Juan-Vidal O, Brungs D, Lu S, Garassino M, Chargualaf M, Zhang Y, Howarth P, Uema D, Lisberg A, Sands J; TROPION-Lung01 Trial Investigators. Ahn MJ, et al. J Clin Oncol. 2024 Sep 9:JCO2401544. doi: 10.1200/JCO-24-01544. Online ahead of print. J Clin Oncol. 2024. PMID: 39250535
143 results